Iovance Biotherapeutics Inc. has granted inducement stock options to 11 new, non-executive employees, covering a total of 164,900 shares of common stock. The stock options have an exercise price of $2.18 per share, matching the closing price on the date of grant, November 20, 2025. The options will vest over a three-year period, with one-third vesting on the first anniversary of each employee's start date and the remainder vesting in eight quarterly installments over the following two years, contingent on continued employment.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9580566-en) on November 21, 2025, and is solely responsible for the information contained therein.